1139 Virtual Meeting
BPS & ELRIG UK joint meeting: Translating Ideas into Therapies

 

 

Evaluation of the neuroprotective mechanisms of 7,8-dihydroxyflavone and generation of sustained release nano/microparticles for improved ocular drug delivery

 

Flavia Messina1, Andrea Cerquone Perpetuini2, Husvinee Sundaramurthi1, Ailis Moran3, Milton English4, Matthew Brooks4, Anand Swaroop4, Madhuri Dandamudi5, Alison L. Reynolds6, Niall O’Reilly7, Breandán N. Kennedy3
1UCD - Conway Institute, 2Novartis, 3UCD - Conway Institute, 4National Eye Institute - NIH, 5WIT - PMBRC, 6UCD - School of Veterinary Medicine, 7WIT - PMBRC

 

 

Introduction/Background & aims 7,8-Dihydroxyflavone (7,8-DHF), a reported TrkB agonist, improves vision in the atp6voe1ucd6 zebrafish model of inherited blindness [1]. Here, the mechanism by which 7,8-DHF restores vision is investigated and biodegradable nano/microparticles for 7,8-DHF ocular drug delivery are characterized.

Method/Summary of work 3 days post fertilized (dpf) sibling or atp6voe1ucd6 larvae (n=5, N=3) were treated with 20-40 µM 7,8-DHF or 0.1% DMSO. Visual behaviour was assessed at 5 dpf by the optokinetic response assay (OKR) . For mechanistic analysis, 60 eyes of 5 dpf atp6voe1ucd6 treated with 0.1% DMSO or 20 µM 7,8-DHF were analysed by RNAseq and differentially expressed genes/pathways identified using Cytoscape and gProfiler. PLGA nano/micro-particles incorporating 7,8-DHF were produced by single emulsion solvent evaporation, encapsulation efficiency analyzed by HPLC, and particle size or shape analysed by dynamic light scattering or scanning electron microscope.

Results/Discussion 20 µM 7,8-DHF rescues atp6voe1ucd6 visual function (p= 0.04). RNAseq identified 15,662 genes of which 58 were down regulated and 213 up regulated by 7,8-DHF. Following gProfiler analyses, among the down-regulated processes are genes related to inflammation, among the up regulated processes are genes related to translation. 7,8-DHF PLGA nanoparticles show 59.14 ± 4.97 % drug encapsulation, mean size of 314 nm; the spherical microparticles of 3-30 µm display drug encapsulation of 72.92 ± 1.121%.

Conclusion(s) 7,8-DHF may rescue vision by decreasing inflammation in the eye. The biodegradable PLGA nano/microparticles display appropriate drug encapsulation and physiochemical properties. Future directions include characterization of efficacy and safety in biological systems.

 

 

Reference(s)

[1]. Daly C, Shine L, Heffernan T, et al. A Brain-Derived Neurotrophic Factor Mimetic Is Sufficient to Restore Cone Photoreceptor Visual Function in an Inherited Blindness Model. Sci Rep-uk. 2017;7(1):11320.